Clinical data | |
---|---|
Trade names | Drixoril, Conex, Dixaphedrine |
AHFS/Drugs.com | Multum Consumer Information |
Pregnancy category |
|
Routes of administration |
Oral |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Biological half-life | 25 hours |
Identifiers | |
|
|
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
ECHA InfoCard | 100.004.595 |
Chemical and physical data | |
Formula | C16H19BrN2 |
Molar mass | 319.24 g/mol |
3D model (Jmol) | |
|
|
|
|
(what is this?) |
Dexbrompheniramine is an antihistamine with anticholinergic properties used to treat allergic conditions such as hay fever or urticaria. It is the pharmacologically active dextrorotatory isomer of brompheniramine. It was formerly marketed in combination with pseudoephedrine under the name Drixoral in the US and Canada.
Dexbrompheniramine is a first generation antihistamine that reduces the effects of natural chemical histamine in the body; sneezing, itching, watery eyes, and runny nose.
MAO inhibitors within 14 days. MAO inhibitors include isocarboxazid, linezolid, phenelzine, rasagiline, selegiline, and tranylcypromine.
Potassium (Cytra, Epiklor, K-Lyte, K-Phos, Kaon, Klor-Con, Polycitra, Urocit-K).
Drinking alcohol can increase side effects of dexbrompheniramine.